Last reviewed · How we verify
orthocaine
orthocaine is a drug. It is currently in unknown development for Dermatomyositis, Induratio penis plastica, Morphea.
Orthocaine is a local anesthetic that was developed in the 1890s. It has been used in powdered form to dust onto painful wounds due to its low solubility in water.
At a glance
| Generic name | orthocaine |
|---|---|
| Therapeutic area | Dermatology |
| Phase | unknown |
Approved indications
- Dermatomyositis
- Induratio penis plastica
- Morphea
- Pemphigus
- Systemic sclerosis
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- orthocaine CI brief — competitive landscape report
- orthocaine updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about orthocaine
What is orthocaine?
orthocaine is a pharmaceutical drug, indicated for Dermatomyositis, Induratio penis plastica, Morphea.
What is orthocaine used for?
orthocaine is indicated for Dermatomyositis, Induratio penis plastica, Morphea, Pemphigus, Systemic sclerosis.
What development phase is orthocaine in?
orthocaine is in unknown.
Related
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Dermatology
- Indication: Drugs for Dermatomyositis
- Indication: Drugs for Induratio penis plastica
- Indication: Drugs for Morphea
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing